Lapatinib (in combination with Xeloda®) offers a new treatment option for women whose disease has returned despite treatment with standard chemotherapies and Herceptin® .

There are very few treatment options available for these women and lapatinib

…{+}

The rest of this article is available to premium members only.
Login or Become a subscriber